Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine and Spironolactone in Myocardial Infarction (CLEAR SYNERGY)
NCT03048825Phase 3Completed
- Sponsor
- Population Health Research Institute
- Start
- Feb 2018
- Primary completion
- Aug 2024
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 14
01
Overview
A Phase 3 trial of colchicine, spironolactone in myocardial infarction (MI), sponsored by Population Health Research Institute. Started Feb 2018; status: completed.
02
Drugs
colchicinespironolactone
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT03048825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03048825.